Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Cancer's Return Shouldn't Limit Elizabeth Edwards, Doctors Say


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
Amenorrhea
Amniocentesis
Amniocentesis and CVS
More...

Related Healthscout Videos
 border=
Zapping Vocal Tumors
Keep Away Ovarian Cancer
Breakthrough for Fatal Lung Disease
Preventing Breast Cancer
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Colon Cancer
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Detrol LA
Diflucan
Ditropan XL
More...

Related News Articles
 border=
Parkinson's Drug May Fight Cancer
Fighting Cancer With a Pen
Health Tip: Take a Childbirth Class
Combo Treatment Ups Survival When Cancer Spreads to Abdominal Lining
More...


Page:  << Prev | 1 | 2 | 3 | 4 | Next >>

A lot will depend on just what kind of breast cancer Mrs. Edwards originally had, something that wasn't divulged at the press conference. Cancers that are "estrogen-receptor positive" -- meaning they can grow under the influence of circulating estrogen -- may be reined in for months or years by hormonal therapy, which has relatively few side effects.

"If she has the option of hormone therapy and responds to it, she may return to her same quality of life and function and do very well," said Dr. Julia Smith, director of the Lynne Cohen Breast Cancer Preventative Care Program at the New York University Cancer Institute and Bellevue Hospital, in New York City. "There is a subset of patients with bone-only disease -- as it appears that she has -- who respond to hormones and do very well for a very long time, possibly well longer than 10 years."

"So, I think that's the hope," Smith said. "If she has hormone receptor negative disease, then you do not have that option anymore. Then you have to put the patient on (stronger) chemotherapy."

Text Continues Below



Depending on the treatment she receives, Elizabeth Edwards could face a "rocky" year ahead, Greene said, although the side effects from the types of systemic chemotherapy and radiation she might receive are not as onerous as those used in the past. She might require a few weeks of radiation first to treat the bone tumor and hopefully eliminate other stray cells, Greene said. And if her cancer is hormone-receptor positive, she could be placed on hormonal treatments for years to come.

"This doesn't necessarily mean that her quality of life is going to be altered," the breast cancer specialist said. "Some patients do say that radiation therapy makes them a bit tired, but it doesn't cause nausea, vomiting, hair loss."

But Smith reiterated that there is ultimately no cure for metastatic disease.

Page:  << Prev | 1 | 2 | 3 | 4 | Next >>

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 3/23/2007

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates





New Features

New ADHD Site!

SOURCES: March 22, 2007, press conference, with John and Elizabeth Edwards, and Dr. Lisa Carey, associate professor of medicine, University of North Carolina School of Medicine's Division of Hematology/Oncology, Chapel Hill; Toby Greene, M.D., breast cancer surgeon, Hackensack University Medical Center, Hackensack, N.J.; Julia Smith, M.D., Ph.D., director, Lynne Cohen Breast Cancer Preventative Care Program at the New York University Cancer Institute and Bellevue Hospital, New York City; Len Lichtenfeld, M.D., deputy chief medical officer, American Cancer Society


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map